| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 20.831 | 23.138 | 27.834 | 35.629 | 46.535 | 55.295 | 57.938 | 50.920 | 75.138 | 87.728 |
| Total Income - EUR | 20.831 | 23.138 | 27.834 | 35.629 | 46.536 | 55.327 | 57.950 | 50.920 | 75.162 | 87.729 |
| Total Expenses - EUR | 22.016 | 16.380 | 19.889 | 26.231 | 29.563 | 28.435 | 33.331 | 31.099 | 44.434 | 76.487 |
| Gross Profit/Loss - EUR | -1.184 | 6.758 | 7.945 | 9.399 | 16.973 | 26.892 | 24.619 | 19.822 | 30.728 | 11.242 |
| Net Profit/Loss - EUR | -1.809 | 6.526 | 6.668 | 9.042 | 16.509 | 26.352 | 24.074 | 19.440 | 30.164 | 9.014 |
| Employees | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Famedica Stragea S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 170 | 19.164 | 16.028 | 13.923 | 32.515 | 26.250 | 21.013 | 15.062 | 9.742 | 32.725 |
| Current Assets | 8.280 | 11.251 | 4.694 | 14.279 | 29.168 | 40.208 | 51.523 | 71.604 | 102.602 | 96.466 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 23 | 0 | 0 | 0 |
| Receivables | 1.705 | 1.942 | 2.377 | 3.782 | 20.805 | 21.157 | 45.997 | 41.041 | 95.512 | 85.742 |
| Cash | 6.575 | 9.309 | 2.317 | 10.497 | 8.363 | 19.051 | 5.503 | 30.562 | 7.089 | 10.724 |
| Shareholders Funds | 7.054 | 13.509 | 6.059 | 14.990 | 31.209 | 41.736 | 54.111 | 73.719 | 103.659 | 112.032 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 1.396 | 16.906 | 14.663 | 13.211 | 30.475 | 24.722 | 18.424 | 12.947 | 8.685 | 17.158 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Famedica Stragea S.r.l.